Ashland Inc.

AI Score

0

Unlock

64.91
-0.52 (-0.79%)
At close: Feb 21, 2025, 3:59 PM
64.89
-0.02%
After-hours: Feb 21, 2025, 03:59 PM EST

Ashland Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018
Intermediates And Solvents Revenue 71M 40M 33M 406M 219M 240M 207M 213M 228M 204M 170M 41M 33M 20M 21M 14M 21M 84M 30M 84M 90M 69M 84M 83M 90M
Intermediates And Solvents Revenue Growth +77.50% +21.21% -91.87% +85.39% -8.75% +15.94% -2.82% -6.58% +11.76% +20.00% +314.63% +24.24% +65.00% -4.76% +50.00% -33.33% -75.00% +180.00% -64.29% -6.67% +30.43% -17.86% +1.20% -7.78% n/a
Life Sciences Revenue 388M 222M 200M 288M 152M 161M 143M 187M 194M 182M 156M 58M 60M 60M 51M 60M 58M n/a n/a n/a n/a n/a n/a n/a n/a
Life Sciences Revenue Growth +74.77% +11.00% -30.56% +89.47% -5.59% +12.59% -23.53% -3.61% +6.59% +16.67% +168.97% -3.33% 0.00% +17.65% -15.00% +3.45% n/a n/a n/a n/a n/a n/a n/a n/a n/a
Personal Care And Household Revenue 336M 169M 129M n/a n/a n/a n/a n/a n/a n/a n/a 51M 46M 42M 41M 52M 42M n/a n/a n/a n/a n/a n/a n/a n/a
Personal Care And Household Revenue Growth +98.82% +31.01% n/a n/a n/a n/a n/a n/a n/a n/a n/a +10.87% +9.52% +2.44% -21.15% +23.81% n/a n/a n/a n/a n/a n/a n/a n/a n/a
Specialty Additives Revenue 293M 157M 122M n/a n/a n/a n/a n/a n/a n/a n/a 57M 53M 48M 45M 51M 50M n/a n/a n/a n/a n/a n/a n/a n/a
Specialty Additives Revenue Growth +86.62% +28.69% n/a n/a n/a n/a n/a n/a n/a n/a n/a +7.55% +10.42% +6.67% -11.76% +2.00% n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Sep 30, 2024Sep 30, 2023Sep 30, 2022Sep 30, 2021Sep 30, 2020Sep 30, 2019Sep 30, 2018Sep 30, 2017Sep 30, 2016
Non-Us Revenue 1.49B 1.56B 1.66B 637M 878M 959M 1.42B 2.01B 2.39B
Non-Us Revenue Growth -4.37% -6.20% +160.60% -27.45% -8.45% -32.46% -29.42% -15.71% n/a
United States Revenue 624M 634M 731M n/a n/a n/a n/a 1.25B 2.56B
United States Revenue Growth -1.58% -13.27% n/a n/a n/a n/a n/a -51.27% n/a

Operating Expense Breakdown

Quarter Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 78M 105M 69M 87M 83M 109M 84M 79M 93M 94M 127M 90M 82M 85M 98M 84M 106M 109M 113M 103M 99M 109M 150M 136M 143M 235M 203M 163M 171M 177M 182M 245M 239M 502M 244M 258M 224M 383M 216M 203M
Selling, General, and Administrative Revenue Growth -25.71% +52.17% -20.69% +4.82% -23.85% +29.76% +6.33% -15.05% -1.06% -25.98% +41.11% +9.76% -3.53% -13.27% +16.67% -20.75% -2.75% -3.54% +9.71% +4.04% -9.17% -27.33% +10.29% -4.90% -39.15% +15.76% +24.54% -4.68% -3.39% -2.75% -25.71% +2.51% -52.39% +105.74% -5.43% +15.18% -41.51% +77.31% +6.40% n/a
Research and Development Revenue 13M 13M 15M 14M 12M 14M 12M 12M 13M 14M 14M 13M 13M 13M 15M 14M 15M 16M 14M 18M 16M 15M 17M 17M 17M 21M 21M 21M 21M 22M 20M 24M 23M 26M 25M 25M 25M 36M 24M 25M
Research and Development Revenue Growth n/a -13.33% +7.14% +16.67% -14.29% +16.67% n/a -7.69% -7.14% n/a +7.69% n/a n/a -13.33% +7.14% -6.67% -6.25% +14.29% -22.22% +12.50% +6.67% -11.76% n/a n/a -19.05% n/a n/a n/a -4.55% +10.00% -16.67% +4.35% -11.54% +4.00% n/a n/a -30.56% +50.00% -4.00% n/a